Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05117086
Other study ID # 1770356
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 1, 2022
Est. completion date December 2024

Study information

Verified date January 2024
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to refine the classification of the effectiveness of the DASH diet for outpatient heart failure (HF) management, using behavioral, clinical, and laboratory correlative science approaches.


Description:

The overall objective of this pilot study is to refine the classification of the effectiveness of the DASH diet for outpatient HF management using behavioral, clinical, and laboratory correlative science approaches. The investigators will integrate the use and evaluation of DASH diet nutrition education in a clinical population using a pragmatic study approach. The investigators will assess dietary behavior change. The investigators will assess the medical effectiveness of the DASH diet to improve patient symptomology and clinical biomarkers. Exploratory investigations will involve metabolomics analyses of plasma samples for biomarker discovery of clinical phenotypes in HF patients, to characterize metabolic profiles related to dietary exposure.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 26
Est. completion date December 2024
Est. primary completion date February 2024
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Heart Failure diagnosis - Guideline directed medical therapy optimization on stable regimen at least 30 days Exclusion Criteria: - BMI < 18/5 kg/m squared - cardiac cachexia - end-stage renal disease or dialysis - acute inflammatory condition - uncontrolled arrhythmias or ischemia - status post heart transplant or implanted left ventricular assist device

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
DASH diet
Nutrition education and counseling on DASH diet, behavioral and lifestyle modifications

Locations

Country Name City State
United States UC Davis Health Center - Cardiology Department Sacramento California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Davis American College of Cardiology

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dietary intake Dietary intake assessed by nutrient analysis of food records Dietary intake at baseline
Primary Dietary intake Dietary intake assessed by nutrient analysis of food records Dietary intake at 3 months
Primary Dietary intake Dietary intake assessed by nutrient analysis of food records Dietary intake at 6 months
Primary Diet score Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition. Dietary intake at baseline
Primary Diet score Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition. Dietary intake at 3 months
Primary Diet score Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition. Dietary intake at 6 months
Primary Blood Pressure Blood Pressure assessed with systolic and diastolic pressure Systolic and diastolic Blood Pressure at baseline
Primary Blood Pressure Blood Pressure assessed with systolic and diastolic pressure Systolic and diastolic Blood Pressure at 3 months
Primary Blood Pressure Blood Pressure assessed with systolic and diastolic pressure Systolic and diastolic Blood Pressure at 6 months
Secondary Heart Failure clinical marker proBNP will be assessed as a marker of severity of heart failure proBNP at baseline
Secondary Heart Failure clinical marker proBNP will be assessed as a marker of severity of heart failure proBNP at 3 months
Secondary Heart Failure clinical marker proBNP will be assessed as a marker of severity of heart failure proBNP at 6 months
Secondary Patient report of HF symptoms Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome. KCCQ at baseline
Secondary Patient report of HF symptoms Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome. KCCQ at 3 months
Secondary Patient report of HF symptoms Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome. KCCQ at 6 months
Secondary Patient report of eating habit self efficacy Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome. Eating Habits at Baseline
Secondary Patient report of eating habit self efficacy Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome. Eating Habits at 3 months
Secondary Patient report of eating habit self efficacy Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome. Eating Habits at 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05654272 - Development of CIRC Technologies
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy